Get the weekly digest
Top current affairs + exam tips, every Monday morning.
📝 AI-generated analysis for exam preparation. This is original educational content curated for competitive exam aspirants.
The Institute of Advanced Virology (IAV) at Thonnakkal, Thiruvananthapuram, has acquired Polymerase Chain Reaction (PCR) testing facility for confirmatory diagnosis of hantavirus infections in Kerala. This development comes as virologists and clinicians in the State raise concerns about hantavirus (scientifically known as Orthohantavirus) potentially being a new emerging pathogen. Kerala's Health department has acknowledged that hantavirus could be responsible for a significant proportion of acute febrile illnesses with renal syndrome and thrombocytopenia (lowered platelet count), currently attributed to suspected leptospirosis. The clinical symptoms of hantavirus-induced Hemorrhagic Fever with Renal Syndrome (HFRS) and leptospirosis are nearly identical, making differential diagnosis without targeted serology tests extremely difficult. The IAV has initiated PCR testing of clinical samples from Thiruvananthapuram Medical College Hospital, though no positive cases have been detected so far. The virus causes two major diseases in humans: Hantavirus Pulmonary Syndrome and HFRS, with the latter being more common in India. HFRS due to hantavirus carries a reported mortality rate of up to 15% in Southeast Asia, though no human-to-human transmission has been documented.
The history of hantavirus detection in Kerala spans nearly three decades, with initial evidence emerging in 1999. [GK] Hantaviruses belong to the family Hantaviridae and are zoonotic viruses transmitted primarily through inhalation of aerosolized particles from the urine, saliva, or droppings of infected rodents.[/GK] In 1999, serological and clinical evidence of hantavirus infection in India was first documented when 30 serum samples from Kochi were sent to the Laboratory of Clinical and Epidemiological Virology at the University of Leuven, Belgium, for testing. Of these, two cases were found to be hanta positive in both IgM and IgG antibody tests. The hanta serotypes identified were Seol virus (SEOV) and Puumala virus (PUUV). [GK] Puumala virus is typically associated with Nephropathia Epidemica, a milder form of HFRS common in Europe, while Seoul virus has a wider global distribution.[/GK]
Take This Week's Quiz
20 cross-topic questions from this week's current affairs
What is India’s first orbital data centre satellite?
10 MayCan data centres in orbit solve for AI models’ soaring energy demand?
9 MayGalaxEye launches Mission Drishti, India’s largest privately developed Earth observation satellite
3 MayIndia’s first State-led Centre of Excellence for space tech launched in Bengaluru
1 MayIn 2014, Kerala reported one probable case of hantavirus-induced HFRS that clinically mimicked leptospirosis, but confirmatory diagnosis was not available at that time. The State carries a huge annual burden of leptospirosis, with farming, sanitation work, and monsoon floods driving the spillover of the pathogen from animals to humans. Rodent-borne hantaviruses are also circulating in the same agro-ecological zones, making human exposure to these viruses highly plausible.
A significant development occurred in December 2025 when researchers Chandy et al published a study in which serum samples from 216 febrile patients presenting at Lisie Hospital, Kochi, were tested for anti-orthohantavirus IgM and IgG antibodies. The findings revealed that 16.2% of samples were positive for anti-orthohantavirus IgM and 11.57% for IgG antibodies, while both IgM and IgG were detected in 4.63% of samples, indicating widespread virus exposure in the population. [GK] The One Health approach, recognizing the interconnection between human, animal, and environmental health, has been promoted by WHO, FAO, and WOAH since 2008 to address such zoonotic disease emergence.[/GK]
Diagnostic Infrastructure Development: • Institute of Advanced Virology (IAV), Thonnakkal, Thiruvananthapuram has acquired PCR testing facility for confirmatory diagnosis of hantavirus infections • Previously, access to both serology tests (IgM ELISA) and molecular diagnostic tests (PCR) for hantavirus was limited across Kerala and the entire country • IAV has initiated routine PCR testing of clinical samples from Thiruvananthapuram MCH for hantavirus
Historical Evidence of Hantavirus in Kerala: • First documented in 1999: 2 out of 30 serum samples from Kochi tested positive for hantavirus antibodies (IgM and IgG) • Serotypes identified: Seol virus (SEOV) and Puumala virus (PUUV) • One probable hantavirus-induced HFRS case reported in 2014 (mimicked leptospirosis)
Seroprevalence Data: • December 2025 study by Chandy et al at Lisie Hospital, Kochi:
Disease Characteristics: • Hantavirus (Orthohantavirus) causes two major diseases: Hantavirus Pulmonary Syndrome and Hemorrhagic Fever with Renal Syndrome (HFRS) • HFRS is more common in India • Mortality rate: up to 15% in Southeast Asia • No human-to-human transmission documented • Clinical symptoms identical to leptospirosis: high-grade fever with myalgia, lowered platelet count, acute kidney injury, hemorrhagic manifestations
Key Stakeholders: • Dr. R. Aravind, Head of Infectious Diseases, Government Medical College, Thiruvananthapuram • E. Sreekumar, Director, Institute of Advanced Virology • Laboratory of Clinical and Epidemiological Virology, University of Leuven, Belgium
Political & Constitutional Dimensions:
From the government's perspective, the acquisition of PCR testing capability at IAV represents a proactive public health response to potential zoonotic disease emergence. The Health department's acknowledgment of hantavirus as a possible emerging pathogen demonstrates scientific temper and transparency in public health communication. The State government's investment in advanced virology infrastructure aligns with the broader One Health framework that India has been implementing.
From the opposition and public health advocacy viewpoint, the delayed establishment of diagnostic facilities—nearly 27 years after initial seropositivity was documented in 1999—raises questions about surveillance priorities. Critics argue that had active surveillance been initiated earlier, the true burden of hantavirus in Kerala could have been better understood. The fact that many cases remain documented as "unconfirmed/probable leptospirosis" for lack of timely diagnosis highlights systemic gaps in differential diagnosis capabilities.
[GK] Article 47 of the Constitution directs the State to regard improvement of public health as among its primary duties.[/GK]
Economic & Financial Impact:
The economic implications are substantial. HFRS, with its 15% mortality rate in Southeast Asia, carries significant healthcare costs through extended hospitalizations, dialysis for acute kidney injury, and management of hemorrhagic complications. The similarity between leptospirosis and hantavirus symptoms means that inappropriate antibiotic treatment (effective against leptospirosis but not hantavirus) not only fails to treat the actual infection but also contributes to antimicrobial resistance and unnecessary healthcare expenditure.
Kerala's agricultural sector, particularly farming communities, faces occupational risk. The State's economy, heavily dependent on agriculture in certain regions, could see productivity losses if hantavirus emerges as a significant public health threat. The healthcare infrastructure investment in IAV represents a long-term public health security measure that could prevent larger economic losses from disease outbreaks.
Social Dimensions:
The social impact is most pronounced among high-risk occupational groups—farmers, sanitation workers, and those exposed to monsoon flooding. These communities already bear the burden of leptospirosis, and the possibility of co-infection with hantavirus compounds their health vulnerability. The December 2025 study's finding that 16.2% of febrile patients showed IgM positivity suggests significant community-level exposure.
Equity considerations arise because differential diagnosis requires sophisticated laboratory infrastructure available primarily in tertiary care centers. Rural populations, who are most exposed to rodent-borne diseases due to their occupational settings, may not have equal access to confirmatory testing. Dr. Aravind's observation that patients deteriorate and die within four to five days highlights the critical importance of timely diagnosis for survival outcomes.
Governance & Administrative Aspects:
The establishment of IAV and its PCR testing capability represents a significant strengthening of Kerala's public health laboratory infrastructure. However, implementation challenges remain. Serology tests have inherent limitations—detectable antibody levels may not appear during the acute phase of disease, and there are risks of hantavirus cross-reacting with other viruses, resulting in false negatives.
The federal structure of India's health system means that while States maintain public health facilities, the National Centre for Disease Control (NCDC) and Indian Council of Medical Research (ICMR) play coordinating roles in disease surveillance. [GK] The Integrated Disease Surveillance Programme (IDSP), launched in 2004, aims to strengthen disease surveillance for early epidemic detection.[/GK] The hantavirus situation underscores the need for better integration between State-level virology institutes and national surveillance frameworks.
The fact that Kerala has never conducted active surveillance for hantavirus despite documented serological evidence represents a governance gap. Moving forward, the challenge lies in establishing routine surveillance, training clinicians in differential diagnosis, and ensuring equitable access to diagnostic facilities across the State's healthcare network.
International Perspective:
Globally, hantavirus emergence is recognized as a One Health issue. [GK] The WHO's Global Health Sector Strategy on Viral Hepatitis and the One Health approach emphasize cross-sectoral collaboration for zoonotic disease control.[/GK] The collaboration with the University of Leuven, Belgium, in 1999 demonstrates the importance of international partnerships in addressing emerging pathogens.
Southeast Asian countries, particularly China and South Korea, have documented higher hantavirus prevalence and mortality. India's experience with HFRS, while less severe than in some neighboring countries, suggests the need for regional surveillance networks. The absence of human-to-human transmission (unlike some other hemorrhagic fevers) is a reassuring factor that simplifies containment strategies.
Short-Term Measures (0-12 months): • Expand PCR testing facilities beyond Thiruvananthapuram to all district hospitals and major tertiary care centers in Kerala to ensure equitable access • Conduct targeted training programs for clinicians on differential diagnosis of febrile illnesses with renal involvement, specifically distinguishing hantavirus-HFRS from leptospirosis • Establish sentinel surveillance sites in high-risk areas (agricultural zones, flood-prone regions) to monitor hantavirus circulation • Develop standardized clinical protocols for management of suspected hantavirus cases, including supportive care protocols for HFRS
Medium-Term Reforms (1-3 years): • Integrate hantavirus surveillance into the existing Integrated Disease Surveillance Programme (IDSP) framework with dedicated funding allocation • Establish a network of laboratories with hantavirus testing capability across the State, modeled on the successful IAV infrastructure • Conduct large-scale seroprevalence studies to determine the true burden of hantavirus infection in Kerala's population • Develop public health communication campaigns targeting high-risk occupational groups (farmers, sanitation workers) about rodent control and prevention measures
Long-Term Vision (3-5 years): • Strengthen the One Health approach by establishing formal coordination between human health, animal health (veterinary services), and environmental health departments for zoonotic disease surveillance • [GK] The National One Health Programme for Prevention and Control of Zoonoses, recommended by various expert committees, should be implemented with specific hantavirus surveillance components.[/GK] • Develop indigenous vaccine development research programs for hantavirus, drawing on international experience from countries like China where hantavirus vaccines are available • Establish a regional hantavirus surveillance network across South Asian Association for Regional Cooperation (SAARC) countries to monitor cross-border disease emergence
International Best Practices: • China: Established comprehensive hantavirus surveillance with rodent reservoir monitoring • South Korea: Developed clinical guidelines for HFRS management that could be adapted for Indian context • United States: The Sin Nombre virus outbreak in 1993 demonstrated the value of rapid diagnostic capability and inter-agency coordination